New drug combo aims to stop dangerous bleeding in adults
NCT ID NCT07189910
Summary
This study is testing a specific sequence of three different medications to treat severe immune thrombocytopenia (ITP), a condition where the immune system attacks blood platelets. Adults with very low platelet counts will first receive two drugs in the hospital for two weeks, then take a third drug as a pill at home for ten more weeks. The goal is to see if this approach can quickly raise platelet counts, keep them stable, and reduce the chance of the condition coming back.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Wuhan Union Hospital
Wuhan, Hubei, 430022,, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.